Changes in the Concentration of Markers Participating in the Regulation of the Apoptosis Receptor Pathway Involving Soluble Tumour Necrosis Factor Ligand Inducing Apoptosis (sTRAIL) and Osteoprotegerin (OPG) in the Serum of Women with Ovarian Cancer—Participation in Pathogenesis or a Possible Clinical Use?

Due to the ability to selectively induce apoptosis in cancer cells, the most interesting target for clinical research is the tumour necrosis factor ligand inducing apoptosis (TRAIL), which binds specific receptors, including osteoprotegerin (OPG). The aim of the study was to analyse the concentratio...

Descripción completa

Detalles Bibliográficos
Autores principales: Mielczarek-Palacz, Aleksandra, Kondera-Anasz, Zdzisława, Smycz-Kubańska, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140464/
https://www.ncbi.nlm.nih.gov/pubmed/32143328
http://dx.doi.org/10.3390/cells9030612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140464/
https://www.ncbi.nlm.nih.gov/pubmed/32143328
http://dx.doi.org/10.3390/cells9030612

Ejemplares similares